menu About Ionis: A force for life Ionis is THE leading innovator in RNA-targeted therapeutics and was purposely designed to: Create a better, more efficient drug discovery platform Establish a new innovation-centered business model, and Maximize the value of every medicine we create and get it to the people who need it most as quickly and as efficiently as possible Today we are a sustainably profitable, multi-product company that is delivering transformative breakthroughs for patients… again and again. A passion to innovate Ionis is guided by world-class scientists and business leaders whose passion to innovate is matched only by their commitment to deliver transformational medicines to patients who need them. Executive Team Leadership Team Board of Directors Brett P. Monia, Ph.D. Chief Executive Officer Elizabeth L. Hougen Executive Vice President, Chief Financial Officer C. Frank Bennett, Ph.D. Executive Vice President, Chief Scientific Officer Onaiza Cadoret-Manier Executive Vice President, Chief Corporate Development and Commercial Officer Richard S. Geary, Ph.D. Executive Vice President, Chief Development Officer Patrick R. O’Neil, Esq. Chief Legal Officer and General Counsel Eric E. Swayze, Ph.D. Executive Vice President, Research Eugene Schneider, M.D. Executive Vice President, Chief Clinical Development Officer About Akcea Therapeutics Akcea is a wholly owned subsidiary of Ionis. Akcea commercializes TEGSEDI™ (inotersen) and WAYLIVRA® (volanesorsen), and with Ionis, is advancing a mature pipeline of novel medicines discovered by Ionis and based on Ionis’ proprietary antisense technology. For more information about Akcea, click here. Contact Us For questions or to request information, please contact us. Contact Us A history of advancing science View our timeline of innovation Pioneering a more efficient way to treat disease Bridging genomic discovery to life-saving therapies, we believe antisense technology is the key to treating the untreatable. Learn about antisense-powered possibilities Fred and Lynne’s story Fred and Lynne have been married for 40+ years. When talking about Fred’s illness, Lynne often looks back to when she said, “I do,” and thinks about how she had no idea at the time what “in sickness and in health” would really mean. See who inspires Ionis ©1989 – 2021 Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc. Akcea Therapeutics® is a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. Contact Suppliers Legal Notice Privacy Policy Social Media Policies